New pathway for treating wet AMD

Prof. Ofra Benny, cofounder and CSO of Israel’s Orsight, has developed a small molecule that (in lab tests) stops the formation of excess blood vessels in the eye, thus preventing the worst effects of wet AMD. It also has prospects for use in cutting off blood supply to tumors.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *